News brief
On July 14, 2026, per Chai Discovery, generative protein and antibody design company raised $400M in a Series C backed by Index Ventures at a valuation of about $3.8B. The company was co-founded by Joshua Meier, Jack Dent, Matthew McPartlon and Jacques Boitreaud.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.chaidiscovery.com ↗Published Jul 14, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月14日，据Chai Discovery官网，蛋白质与抗体生成式设计公司完成4亿美元C轮融资，由Index Ventures等支持，估值约38亿美元。公司由Joshua Meier、Jack Dent、Matthew McPartlon和Jacques Boitreaud共同创立。